Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Otitis Externa D010032 8 associated lipids
Burns D002056 34 associated lipids
Body Weight D001835 333 associated lipids
Peritonitis D010538 38 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Vaginitis D014627 6 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Dermatomycoses D003881 17 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Aspergillosis D001228 5 associated lipids
Leishmaniasis D007896 19 associated lipids
HIV Seropositivity D006679 15 associated lipids
Influenza, Human D007251 11 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Mycoses D009181 18 associated lipids
Gonorrhea D006069 7 associated lipids
Xerostomia D014987 6 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Blastomycosis D001759 5 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Catalán A et al. In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18280967
Iwaki T et al. Multiple functions of ergosterol in the fission yeast Schizosaccharomyces pombe. 2008 Microbiology (Reading, Engl.) pmid:18310029
Oliver BG et al. Polyene susceptibility is dependent on nitrogen source in the opportunistic pathogen Candida albicans. 2008 J. Antimicrob. Chemother. pmid:18343803
O'Grady MJ and Dempsey EM Antifungal prophylaxis for the prevention of neonatal candidiasis? 2008 Acta Paediatr. pmid:18363952
Lee JJ et al. 5-HT1A receptor-mediated activation of a G-protein-coupled inwardly rectifying K+ current in rat medial preoptic area neurons. 2008 Eur. J. Pharmacol. pmid:18367171
Quirce S et al. Generalized dermatitis due to oral nystatin. 1991 Contact Derm. pmid:1838322
Maza PK et al. Interaction of epithelial cell membrane rafts with Paracoccidioides brasiliensis leads to fungal adhesion and Src-family kinase activation. 2008 Microbes Infect. pmid:18403242
Jackson SK et al. Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response. 2008 J. Leukoc. Biol. pmid:18403647
McFarland MJ et al. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. 2008 Mol. Pharmacol. pmid:18436710
Isaacs D Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing? 2008 Curr. Opin. Infect. Dis. pmid:18448968
Carvalho CP et al. Expression of a Canavalia brasiliensis lectin (ConBr) precursor in Pichia pastoris. 2008 Protein Pept. Lett. pmid:18473942
Takada M et al. Vasotocin has the potential to inhibit basolateral Na(+)/K (+)-pump current across isolated skin of tree frog in vitro, via its V(2)-type receptor/cAMP pathway. 2008 J. Comp. Physiol. B, Biochem. Syst. Environ. Physiol. pmid:18536923
Hombach J et al. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin. 2009 J Pharm Sci pmid:18563796
Oji C and Chukwuneke F Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. 2008 Oral Maxillofac Surg pmid:18618163
Su CW et al. Clinical inquiries. What is the best treatment for oral thrush in healthy infants? 2008 J Fam Pract pmid:18625176
Liu G et al. Nystatin interferes with the effects of N-methyl-N'-nitro-N-nitrosoguanidine on sphingolipid metabolism in human FL cells. 2008 Lipids pmid:18629562
Hersey-Benner C Diarrhea in a rabbit. Cyniclomyces guttulatus yeast. 2008 Lab Anim (NY) pmid:18650820
Kaufman DA Prevention of invasive Candida infections in preterm infants: the time is now. 2008 Expert Rev Anti Infect Ther pmid:18662105
Yin X et al. Differential signaling pathways in angiotensin II- and epidermal growth factor-stimulated hepatic C9 cells. 2008 Mol. Pharmacol. pmid:18687808
Van Hamme E et al. Clathrin- and caveolae-independent entry of feline infectious peritonitis virus in monocytes depends on dynamin. 2008 J. Gen. Virol. pmid:18753224
Placzek EA et al. Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. 2008 J. Neurochem. pmid:18778304
Geerts GA et al. Effect of an antifungal denture liner on the saliva yeast count in patients with denture stomatitis: a pilot study. 2008 J Oral Rehabil pmid:18793352
Llabot JM et al. Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance. 2009 J Pharm Sci pmid:18803261
Volkmer E et al. Successful nystatin powder treatment of posttraumatic invasive Aspergillus fumigatus wound infection refractory to systemic antifungal therapy. 2009 J Trauma pmid:18815576
Agarkova I et al. Chlorovirus-mediated membrane depolarization of Chlorella alters secondary active transport of solutes. 2008 J. Virol. pmid:18842725
Studdert VP and Hughes KL A clinical trial of a topical preparation of miconazole, polymyxin and prednisolone in the treatment of otitis externa in dogs. 1991 Aust. Vet. J. pmid:1888310
da Silva WJ et al. Effects of nystatin, fluconazole and propolis on poly(methyl methacrylate) resin surface. 2008 Braz Dent J pmid:18949289
Milánkovits M [Vaginal infections associated with bacterial vaginosis and periodontal disease--effective diagnostic and therapeutic possibilities]. 2008 Orv Hetil pmid:18977743
Hahn GM et al. Interaction of amphotericin B and 43 degrees hyperthermia. 1977 Cancer Res. pmid:189913
Lippiat JD Whole-cell recording using the perforated patch clamp technique. 2008 Methods Mol. Biol. pmid:18998090
Wong AM et al. Apical versus basolateral P2Y(6) receptor-mediated Cl(-) secretion in immortalized bronchial epithelia. 2009 Am. J. Respir. Cell Mol. Biol. pmid:19011163
Brautaset T et al. Improved antifungal polyene macrolides via engineering of the nystatin biosynthetic genes in Streptomyces noursei. 2008 Chem. Biol. pmid:19022180
Ganesan K et al. Prophylactic oral nystatin for preterm babies under 33 weeks' gestation decreases fungal colonisation and invasive fungaemia. 2009 Arch. Dis. Child. Fetal Neonatal Ed. pmid:19036756
Marconi M et al. Potassium current in mature bovine spermatozoa. 2008 Nov-Dec Syst Biol Reprod Med pmid:19052961
Preobrazhenskaya MN et al. Chemical modification and biological evaluation of new semisynthetic derivatives of 28,29-Didehydronystatin A1 (S44HP), a genetically engineered antifungal polyene macrolide antibiotic. 2009 J. Med. Chem. pmid:19055412
Katsu T et al. Precise size determination of amphotericin B and nystatin channels formed in erythrocyte and liposomal membranes based on osmotic protection experiments. 2008 Anal Sci pmid:19075463
Horn R Diffusion of nystatin in plasma membrane is inhibited by a glass-membrane seal. 1991 Biophys. J. pmid:1912275
Carter GC et al. HIV entry in macrophages is dependent on intact lipid rafts. 2009 Virology pmid:19185899
Broughton MC et al. Polyene resistance in ergosterol producing strains of Candida albicans. 1991 Jan-Feb Mycoses pmid:1922193
Xu L et al. Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts. 2009 FEBS Lett. pmid:19223002
Van Leeuwen MR et al. The polyene antimycotics nystatin and filipin disrupt the plasma membrane, whereas natamycin inhibits endocytosis in germinating conidia of Penicillium discolor. 2009 J. Appl. Microbiol. pmid:19228256
Howell A et al. Oral nystatin prophylaxis and neonatal fungal infections. 2009 Arch. Dis. Child. Fetal Neonatal Ed. pmid:19321509
Zotchev S and Caffrey P Genetic analysis of nystatin and amphotericin biosynthesis. 2009 Meth. Enzymol. pmid:19362643
Lamm CG et al. Pathology in practice. Fungal dermatitis in a camel caused by Candida albicans. 2009 J. Am. Vet. Med. Assoc. pmid:19366330
Signoretto C et al. Support for the role of Candida spp. in extensive caries lesions of children. 2009 New Microbiol. pmid:19382675
Lamberti Y et al. Cholesterol-dependent attachment of human respiratory cells by Bordetella pertussis. 2009 FEMS Immunol. Med. Microbiol. pmid:19385994
Redding S et al. Inhibition of Candida albicans biofilm formation on denture material. 2009 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:19426921
Koide N et al. Nystatin-induced nitric oxide production in mouse macrophage-like cell line RAW264.7. 2009 Microbiol. Immunol. pmid:19457171
Padilha MM et al. Anti-inflammatory activity of aqueous and alkaline extracts from mushrooms (Agaricus blazei Murill). 2009 J Med Food pmid:19459738
Violaris K et al. Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. 2010 Am J Perinatol pmid:19504425
Migalovich HS et al. Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media. 2009 Cancer Res. pmid:19509228
Urban VM et al. Superficial distribution and identification of antifungal/antimicrobial agents on a modified tissue conditioner by SEM-EDS microanalysis: a preliminary study. 2009 J Prosthodont pmid:19515168
Van Cutsem J The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. 1991 Am. J. Obstet. Gynecol. pmid:1951575
Ribeiro MG et al. Phenotypic and genotypic characterization of Prototheca zopfii in a dog with enteric signs. 2009 Res. Vet. Sci. pmid:19520405
Mlot C Microbiology. Antibiotics in nature: beyond biological warfare. 2009 Science pmid:19556482
Rosato A et al. In vitro synergic efficacy of the combination of Nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species. 2009 Phytomedicine pmid:19616925
de la Borbolla JM et al. Late reaction to oral nystatin: the importance of patch testing. 2009 J Investig Allergol Clin Immunol pmid:19639730
Maldonado-Celis ME et al. Apple procyanidins activate apoptotic signaling pathway in human colon adenocarcinoma cells by a lipid-raft independent mechanism. 2009 Biochem. Biophys. Res. Commun. pmid:19666002
Jared SR et al. Actions of antidiuretic hormone analogues on intact and nystatin-permeabilized frog skins. 2009 Exp. Physiol. pmid:19666695
Bernstein JM and Aucott W The BIPP introducer. 2009 Clin Otolaryngol pmid:19674006
Harvey AL and Marshall IG The actions of three diaminopyridines on the chick biventer cervicis muscle. 1977 Eur. J. Pharmacol. pmid:196864
Sakeer K et al. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. 2010 Jul-Aug Pharm Dev Technol pmid:19772376
Kaomongkolgit R et al. Antifungal activity of alpha-mangostin against Candida albicans. 2009 J Oral Sci pmid:19776506
Scardina GA et al. Chronic hyperplastic candidosis: a pilot study of the efficacy of 0.18% isotretinoin. 2009 J Oral Sci pmid:19776507
Austin N et al. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. 2009 Cochrane Database Syst Rev pmid:19821309
Zhang Y et al. A marine sulfate-reducing bacterium producing multiple antibiotics: biological and chemical investigation. 2009 Mar Drugs pmid:19841718
Kang YS et al. Clathrin-independent internalization of normal cellular prion protein in neuroblastoma cells is associated with the Arf6 pathway. 2009 J. Cell. Sci. pmid:19843586
Záruba K et al. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. 1991 Am. J. Kidney Dis. pmid:1986569
Bílková E et al. Targeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate. 2010 Int J Pharm pmid:19874880
Muñante-Cárdenas JL et al. Treating oral histoplasmosis in an immunocompetent patient. 2009 J Am Dent Assoc pmid:19884394
Bernbeck B et al. Long time survival after reduced chemotherapy ina 15-year-old patient with AML and Candida krusei sepsis and eye involvement. 2009 Nov-Dec Klin Padiatr pmid:19890793
Ogita A et al. Targeted yeast vacuole disruption by polyene antibiotics with a macrocyclic lactone ring. 2010 Int. J. Antimicrob. Agents pmid:19910165
de Aguiar MM et al. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. 2010 Drug Dev Ind Pharm pmid:19954405
Preobrazhenskaya MN et al. Synthesis and study of the antifungal activity of new mono- and disubstituted derivatives of a genetically engineered polyene antibiotic 28,29-didehydronystatin A1 (S44HP). 2010 J. Antibiot. pmid:19960041
Woo KY et al. Peristomal skin complications and management. 2009 Adv Skin Wound Care pmid:20026934
Jacobs WR et al. Role of cytosolic Ca in renal tubule damage induced by anoxia. 1991 Am. J. Physiol. pmid:2003577
Young JP et al. Acetylsalicylic acid enhances purinergic receptor-mediated outward currents in rat megakaryocytes. 2010 Am. J. Physiol., Cell Physiol. pmid:20042731
Ulrych A et al. Dissociation of nystatin and amphotericin analogues: characterisation of minor anti-fungal macrolides. 2010 Eur J Mass Spectrom (Chichester, Eng) pmid:20065516
Semis R et al. Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds. 2010 Mycopathologia pmid:20069459
Dagnino L et al. Sodium-dependent nucleoside transport in mouse leukemia L1210 cells. 1991 J. Biol. Chem. pmid:2007583
Samaranayake YH et al. The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata. 2010 Med. Mycol. pmid:20092419
Martínez-Beneyto Y et al. Use of antifungal agents for oral candidiasis: results of a national survey. 2010 Int J Dent Hyg pmid:20096082
Peacock G et al. Accuracy and precision of manufacturer-supplied liquid medication administration devices before and after patient education. 2010 Jan-Feb J Am Pharm Assoc (2003) pmid:20097644
Hirota H et al. YS-822A, a new polyene macrolide antibiotic. II. Planar structure of YS-822A. 1991 J. Antibiot. pmid:2010357
Shamsul HM et al. The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2. 2010 Immunology pmid:20113368
Dalben-Dota KF et al. Antifungal activity of propolis extract against yeasts isolated from vaginal exudates. 2010 J Altern Complement Med pmid:20192913
Mete E et al. Synthesis and antifungal activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols. 2010 Arch. Pharm. (Weinheim) pmid:20232370
A controlled trial of nystatin for the candidiasis hypersensitivity syndrome. 1991 N. Engl. J. Med. pmid:2027363
Böckle BC et al. Oral mucous squamous cell carcinoma-an anticipated consequence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). 2010 J. Am. Acad. Dermatol. pmid:20304522
López-Martínez R Candidosis, a new challenge. 2010 Clin. Dermatol. pmid:20347660
te Welscher YM et al. Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol. 2010 Antimicrob. Agents Chemother. pmid:20385867
Fan SR and Liu XP In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. 2011 Mycoses pmid:20406393
Field EA Discontinuation concern. 2010 Br Dent J pmid:20448592
Levenson C et al. Preventing postoperative burn wound aspergillosis. 1991 Mar-Apr J Burn Care Rehabil pmid:2050719
Pontes HA et al. Oral candidiasis mimicking an oral squamous cell carcinoma: report of a case. 2012 Gerodontology pmid:20633054
Aydemir C et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. 2011 Arch. Dis. Child. Fetal Neonatal Ed. pmid:20659937
Yap FB et al. Penicillium marneffei infection in an African man. 2010 Dermatol. Online J. pmid:20673530
Chanteloup NK et al. The extra-intestinal avian pathogenic Escherichia coli strain BEN2908 invades avian and human epithelial cells and survives intracellularly. 2011 Vet. Microbiol. pmid:20708353
Rae J et al. Low access resistance perforated patch recordings using amphotericin B. 1991 J. Neurosci. Methods pmid:2072734
Schilling T and Eder C Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation. 2010 Cell. Immunol. pmid:20832779